Global Blood Therapeutics Target Price

Explore Global Blood Therapeutics's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$68.49

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2022-02-16	Goldman SachsPaul Choi	$69	0.7% upside
2022-02-08	JefferiesAkash Tewari	$68	0.7% downside
2022-01-07	Wells FargoYanan Zhu	$70	2.2% upside
2021-12-17	Piper SandlerJoseph Catanzaro	$40	41.6% downside
2021-08-04	Cantor FitzgeraldAlethia Young	$110	60.6% upside
2021-08-04	Truist FinancialJoon Lee	$50	27% downside
2021-06-28	J.P. MorganTessa Romero	$36	47.4% downside
2021-05-06	Canaccord GenuityJohn Newman	$40	41.6% downside

Global Blood Therapeutics (GBT) FAQ

Stockcircle tracks target price for Global Blood Therapeutics (GBT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Global Blood Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main GBT overview so you can move from this figure to the surrounding analysis quickly.